Maternal "mirror" syndrome: Evaluating the benefits of fetal therapy.

IF 2.7 2区 医学 Q2 GENETICS & HEREDITY
Prenatal Diagnosis Pub Date : 2024-07-01 Epub Date: 2024-05-16 DOI:10.1002/pd.6589
Joanna Sichitiu, Fawaz Alkazaleh, Roel de Heus, Nimrah Abbasi, Tim van Mieghem, Johannes Keunen, Rory Windrim, Gareth Seaward, Edmond N Kelly, Liesbeth Lewi, Jan Deprest, Greg Ryan, Shiri Shinar
{"title":"Maternal \"mirror\" syndrome: Evaluating the benefits of fetal therapy.","authors":"Joanna Sichitiu, Fawaz Alkazaleh, Roel de Heus, Nimrah Abbasi, Tim van Mieghem, Johannes Keunen, Rory Windrim, Gareth Seaward, Edmond N Kelly, Liesbeth Lewi, Jan Deprest, Greg Ryan, Shiri Shinar","doi":"10.1002/pd.6589","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate maternal and perinatal outcomes following fetal intervention in the context of maternal \"mirror\" syndrome.</p><p><strong>Study design: </strong>A multicenter retrospective study of all cases of fetal hydrops complicated by maternal \"mirror\" syndrome and treated by any form of fetal therapy between 1995 and 2022. Medical records and ultrasound images of all cases were reviewed. \"Mirror\" syndrome was defined as fetal hydrops and/or placentomegaly associated with the maternal development of pronounced edema, with or without pre-eclampsia. Fetal hydrops was defined as the presence of abnormal fluid collections in ≥2 body cavities.</p><p><strong>Results: </strong>Twenty-one pregnancies met the inclusion criteria. Causes of fetal hydrops and/or placentomegaly included fetal lung lesions (n = 9), twin-twin transfusion syndrome (n = 6), severe fetal anemia (n = 4), and others (n = 2). Mean gestational age at \"mirror\" presentation was 27.0 ± 3.8 weeks. Maternal \"mirror\" syndrome was identified following fetal therapeutic intervention in 14 cases (66.6%). \"Mirror\" symptoms resolved or significantly improved before delivery in 8 (38.1%) cases with a mean interval from fetal intervention to maternal recovery of 13.1 days (range 4-35). Three women needed to be delivered because of worsening \"mirror\" syndrome. Of the 21 pregnancies treated (27 fetuses), there were 15 (55.5%) livebirths, 7 (25.9%) neonatal deaths and 5 (18.5%) intra-uterine deaths.</p><p><strong>Conclusion: </strong>Following successful treatment and resolution of fetal hydrops, maternal \"mirror\" syndrome can improve or sometimes completely resolve before delivery. Furthermore, the recognition that \"mirror\" syndrome may arise only after fetal intervention necessitates hightened patient maternal surveillance in cases of fetal hydrops.</p>","PeriodicalId":20387,"journal":{"name":"Prenatal Diagnosis","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prenatal Diagnosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pd.6589","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate maternal and perinatal outcomes following fetal intervention in the context of maternal "mirror" syndrome.

Study design: A multicenter retrospective study of all cases of fetal hydrops complicated by maternal "mirror" syndrome and treated by any form of fetal therapy between 1995 and 2022. Medical records and ultrasound images of all cases were reviewed. "Mirror" syndrome was defined as fetal hydrops and/or placentomegaly associated with the maternal development of pronounced edema, with or without pre-eclampsia. Fetal hydrops was defined as the presence of abnormal fluid collections in ≥2 body cavities.

Results: Twenty-one pregnancies met the inclusion criteria. Causes of fetal hydrops and/or placentomegaly included fetal lung lesions (n = 9), twin-twin transfusion syndrome (n = 6), severe fetal anemia (n = 4), and others (n = 2). Mean gestational age at "mirror" presentation was 27.0 ± 3.8 weeks. Maternal "mirror" syndrome was identified following fetal therapeutic intervention in 14 cases (66.6%). "Mirror" symptoms resolved or significantly improved before delivery in 8 (38.1%) cases with a mean interval from fetal intervention to maternal recovery of 13.1 days (range 4-35). Three women needed to be delivered because of worsening "mirror" syndrome. Of the 21 pregnancies treated (27 fetuses), there were 15 (55.5%) livebirths, 7 (25.9%) neonatal deaths and 5 (18.5%) intra-uterine deaths.

Conclusion: Following successful treatment and resolution of fetal hydrops, maternal "mirror" syndrome can improve or sometimes completely resolve before delivery. Furthermore, the recognition that "mirror" syndrome may arise only after fetal intervention necessitates hightened patient maternal surveillance in cases of fetal hydrops.

母体 "镜像 "综合征:评估胎儿治疗的益处。
研究目的研究设计:多中心回顾性研究:1995 年至 2022 年期间,对所有并发母体 "镜像 "综合征并接受任何形式胎儿治疗的胎儿水肿病例进行研究。研究回顾了所有病例的病历和超声图像。"镜像 "综合征是指胎儿水肿和/或胎盘肿大伴有母体明显水肿,并伴有或不伴有子痫前期。胎儿水肿的定义是胎儿体腔内有≥2个异常液体聚集:结果:21 名孕妇符合纳入标准。胎儿水肿和/或胎盘肿大的原因包括胎儿肺部病变(9 例)、双胎输血综合征(6 例)、严重胎儿贫血(4 例)及其他(2 例)。出现 "镜像 "时的平均孕周为 27.0 ± 3.8 周。14例(66.6%)患者在接受胎儿治疗干预后发现了母体 "镜像 "综合征。8例(38.1%)产妇的 "镜像 "症状在分娩前得到缓解或明显改善,从胎儿干预到产妇康复的平均间隔时间为13.1天(4-35天)。有 3 名产妇因 "镜像 "综合征恶化而需要分娩。在接受治疗的 21 例孕妇(27 个胎儿)中,有 15 例(55.5%)活产,7 例(25.9%)新生儿死亡,5 例(18.5%)宫内死亡:结论:在成功治疗并解决胎儿水肿问题后,产妇 "镜像 "综合征可在分娩前得到改善,有时甚至完全缓解。此外,由于认识到 "镜像 "综合征可能仅在胎儿干预后才会出现,因此有必要加强对胎儿肾积水病例中孕产妇的监控。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Prenatal Diagnosis
Prenatal Diagnosis 医学-妇产科学
CiteScore
5.80
自引率
13.30%
发文量
204
审稿时长
2 months
期刊介绍: Prenatal Diagnosis welcomes submissions in all aspects of prenatal diagnosis with a particular focus on areas in which molecular biology and genetics interface with prenatal care and therapy, encompassing: all aspects of fetal imaging, including sonography and magnetic resonance imaging; prenatal cytogenetics, including molecular studies and array CGH; prenatal screening studies; fetal cells and cell-free nucleic acids in maternal blood and other fluids; preimplantation genetic diagnosis (PGD); prenatal diagnosis of single gene disorders, including metabolic disorders; fetal therapy; fetal and placental development and pathology; development and evaluation of laboratory services for prenatal diagnosis; psychosocial, legal, ethical and economic aspects of prenatal diagnosis; prenatal genetic counseling
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信